1-(4-Chlorophenyl)-3-[4-ethyl-5-(methylsulfanyl)-4H-1,2,4-triazol-3-yl]-1,4-dihydropyridazin-4-one

Catalog No. :
ACJFSZ817
CAS No. :
478077-60-0
Molecular Formula :
C15H14ClN5OS
Molecular Weight :
347.83

IUPAC Name:1-(4-chlorophenyl)-3-(4-ethyl-5-(methylthio)-4H-1,2,4-triazol-3-yl)pyridazin-4(1H)-one

1-(4-Chlorophenyl)-3-[4-ethyl-5-(methylsulfanyl)-4H-1,2,4-triazol-3-yl]-1,4-dihydropyridazin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$287.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Chlorophenyl)-3-[4-ethyl-5-(methylsulfanyl)-4H-1,2,4-triazol-3-yl]-1,4-dihydropyridazin-4-one
IUPAC Name1-(4-chlorophenyl)-3-(4-ethyl-5-(methylthio)-4H-1,2,4-triazol-3-yl)pyridazin-4(1H)-one
MDL No.MFCD01871678
Molecular FormulaC15H14ClN5OS
Molecular Weight347.83
SMILESO=C1C(C2=NN=C(SC)N2CC)=NN(C3=CC=C(Cl)C=C3)C=C1
InChI KeyCRXSFVREPRRBKT-UHFFFAOYSA-N
Synonym1-(4-CHLOROPHENYL)-3-[4-ETHYL-5-(METHYLSULFANYL)-4H-1,2,4-TRIAZOL-3-YL]-4(1H)-PYRIDAZINONE;1-(4-chlorophenyl)-3-[4-ethyl-5-(methylsulfanyl)-4H-1,2,4-triazol-3-yl]-1,4-dihydropyridazin-4-one;4(1H)-Pyridazinone, 1-(4-chlorophenyl)-3-[4-ethyl-5-(methylthio)-4H-1,2,4-triazol-3-yl]-
CAS No.478077-60-0

Synthetic Route by SureRoute

1. ACJFSZ817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJFSZ817 route product structure diagram
    ACJFSZ817478077-60-0
Inquiry

2. ACJFSZ817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHZRV039 route compound structure diagram
    ACHZRV0391679-18-1 In Stock
  4. Then
  5. ACJFSZ817 route product structure diagram
    ACJFSZ817478077-60-0
Inquiry

Comments (0)